Fas Ligand (CD95L) and B7 Expression on Dendritic Cells Provide Counter-Regulatory Signals for T Cell Survival and Proliferation

Journal of Immunology

Volumn 158, Issue 12, 1997, Pages 5676-5684

  Lu, Lina ^a   Qian, Shiguang ^a   Hershberger, Pamela A ^a   Rudert, William A ^c   Lynch, David H ^d   Thomson, Angus W ^a,b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; DNA FRAGMENT; FAS LIGAND; FASL PROTEIN, MOUSE; FASLG PROTEIN, HUMAN; MEMBRANE ANTIGEN; MEMBRANE PROTEIN;

ANIMAL; APOPTOSIS; ARTICLE; C57BL MOUSE; CELL SURVIVAL; CYTOLOGY; DENDRITIC CELL; HUMAN; LEUKEMIA CELL LINE; LYMPHOCYTE ACTIVATION; MALE; MOUSE; PHYSIOLOGY; SIGNAL TRANSDUCTION; SPECTROPHOTOMETRY; SPLEEN; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD80; ANTIGENS, SURFACE; APOPTOSIS; CELL SURVIVAL; DENDRITIC CELLS; DNA FRAGMENTATION; FAS LIGAND PROTEIN; HUMANS; JURKAT CELLS; LYMPHOCYTE ACTIVATION; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; SIGNAL TRANSDUCTION; SPECTROPHOTOMETRY; SPLEEN; T-LYMPHOCYTES;

EID: 0031570408     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Steinman, R. M. 1991. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9:271.
2. Austyn, J. M. 1993. The initiation of immune responses and allograft rejection. In Immunology of Heart und Lung Transplantation. M. L. Rose and M. H. Yacoub, eds. Little, Brown & Co., Boston, pp. 22-41.
3. Thomson, A. W., L. Lu, N. Murase, A. J. Demetris, A. S. Rao, and T. E. Starzl. 1995. Microchimerism, dendritic cell progenitors and transplantation tolerance. Stem Cells 13:622.
4. Jenkinson, E. J., P. Jhittay, R. Kingston, and J. J. T. Owen. 1985. Studies of the role of the thymic environment in the induction of tolerance to MHC antigens. Transplantation 39:331.
5. Matzinger, P., and S. Guerder. 1989. Does T-cell tolerance require a dedicated antigen-presenting cell? Nature 338:74.
6. Zamoyska, R., H. Waldmann, and P. Matzinger. 1989. Peripheral tolerance mechanisms prevent the development of autoreactive T cells in chimeric grafts with two minor incompatible thymuses. Eur. J. Immunol. 19:111.
7. Knight, S. C., R. Hunt, C. Dorse, and P. B. Medawar. 1985. Influence of dendritic cells on rumor growth. Proc. Natl. Acad. Sci. USA 82:4495.
8. Clare-Salzler, M. J., J. Brooks, A. Chai, K. Van Herle, and C. Anderson. 1992. Prevention of diabetes in nonobese diabetic mice by dendritic cell transfer. J. Clin. Invest. 90:741.
9. Finkelman, F. D., A. Lees, R. Bimbaum, W. C. Gause, and S. C. Morris. 1996. Dendritic cells can present antigen in vivo in a tolerogenic or immunogenic fashion. J. Immunol. 157:1406.
10. Khoury, S. J., L. Gallon, W. Chen, K. Betres, M. E. Russell, W. W. Hancock, C. B. Carpenter, M. H. Sayegh, and H. L. Weiner. 1995. Mechanisms of acquired thymic tolerance in experimental autoimmune encephalomyelitis: thymic dendritic-enriched cells induce specific peripheral T cell unresponsiveness in vivo. J. Exp. Med. 182:357.
11. -) induce alloantigen-specific hyporesponsiveness in murine T lymphocytes. Transplantation 60:1539.
12. -) prolong cardiac allograft survival in non-immunosuppressed recipients. Transplantation 62:659.
13. Khoury, S. J., L. Gallon, R. R. Verburg, A. Chandraker, R. Peach, P. S. Linsley, L. A. Turka, W. W. Hancock, and M. H. Sayegh. 1996. Ex vivo treatment of antigen-presenting cells with CTLA4Ig and peptide prevents experimental allergic encephalomyelitis in the Lewis rat. J. Immunol. 157:3700.
14. Starzl, T. E., A. J. Demetris, N. Murase, S. Ildstad, C. Ricordi, and M. Trucco. 1992. Cell migration, chimerism, and graft acceptance. Lancet 339:1579.
15. Starzl, T. E., A. J. Demetris, M. Trucco, N. Murase, C. Ricordi, S. Ildstad, H. Ramos, S. Todo, A. Tzakis, J. J. Fung, M. Nalesnik, W. A. Rudert, and M. Kocova. 1993. Cell migration and chimerism after whole organ transplantation: the basis of graft acceptance. Hepatology 17:1127.
16. Lu, L., W. A. Rudert, S. Qian, D. McCaslin, F. Fu, A. S. Rao, M. Trucco, J. J. Fung, T. E. Starzl, and A. W. Thomson. 1995. Growth of donor-derived dendritic cells from the bone marrow of liver allograft recipients in response to granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 182:379.
17. Green, D. R., and D. W. Scott. 1994. Activation-induced apoptosis in lymphocytes. Curr. Opin. Immunol. 6:476.
18. Watanabe-Fukunaga, R., C. I. Brannan, N. G. Copeland, N. A. Jenkins, and S. Nagata. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314.
19. Lynch, D. H., M. L. Watson, M. R. Alderson, P. R. Baum, R. E. Miller, T. Tough, M. Gibson, T. Davis-Smith, C. A. Smith, K. Hunter, et al. 1994. The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster. Immunity 1:131.
20. Takahashi, T., M. Tanaka, C. I. Brannan, N. A. Jenkins, N. G. Copeland, T. Suda, and S. Nagata. 1994. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76:969.
21. Lynch, D. H., F. Ramsdell, and M. R. Alderson. 1995. Fas and FasL in the homeostatic regulation of immune responses. Immunol. Today 16:569.
22. Alderson, M. R., R. J. Armitage, E. Maraskovsky, T. W. Tough, E. Roux, K. Schooley, F. Ramsdell, and D. H. Lynch. 1993. Fas transduces activation signals in normal human T lymphocytes. J. Exp. Med. 178:2231.
23. Singer, G. G., and A. K. Abbas. 1994. The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1:365.
24. Dhein, J., H. Walczak, C. Baumler, K.-M. Debatin, and P. H. Krammer. 1995. Autocrine T cell suicide mediated by APO-1 (Fas/CD95). Nature 373:438.
25. Brunner, T., R. J. Mogil, D. LaFace, N. J. Yoo, A. Mahboubl, F. Echeverri, S. J. Martin, W. R. Force, D. H. Lynch, C. F. Ware, and D. R. Green. 1995. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373:441.
26. Ju, S.-T., D. J. Panka, H. Cui, R. Ettinger, M. El-Khatib, D. H. Sherr, B. Z. Stanger, and A. Marshak-Rothsiein. 1995. Fas (CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373:444.
27. Süss, G., and K. Shortman. 1996. A subclass of dendritic cells kills CD4 T cells via Fas/Fas ligand-induced apoptosis. J. Exp. Med. 183:1789.
28. Inaba, K., M. Inaba, N. Romani, H. Aya, M. Degochi, S. Ikehara, S. Muramatsu, and R. M. Steinman. 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176:1693.
29. Lu, L., C. A. Bonham, F. G. Chambers, S. C. Watkins, R. A. Hoffman, R. L. Simmons, and A. W. Thomson. 1996. Induction of nitric oxide synthase in mouse dendritic cells by interferon γ, endotoxin and interaction with allogeneic T cells: nitric oxide production is associated with dendritic cell apoptosis. J. Immunol. 157:3577.
30. Lu, L., J. Woo, A. S. Rao, Y. Li, S. C. Watkins, S. Qian, T. E. Starzl, A. J. Demetris, and A. W. Thomson. 1994. Propagation of dendritic cell progenitors from normal mouse liver using GM-CSF and their maturational development in the presence of type-1 collagen. J. Exp. Med. 179:1823.
31. Li, Y.-S., K. Hayakawa, and R. R. Hardy. 1993. The regulated expression of B lineage associated genes during B cell differentiation in bone marrow and fetal liver. J. Exp. Med. 178:951.
32. Matzinger, P. 1991. The JAM test: a simple assay for DNA fragmentation and cell death. J. Immunol. Methods 145:185.
33. McCarthy, S. A., R. N. Cachione, M. S. Mainwaring, and J. S. Cairns. 1992. The effects of immunosuppressive drugs on the regulation of activation-induced apoptotic cell death in thymocytes. Transplantation 54:543.
34. Gavrieli, Y., Y. Sherman, and S. A. Ben-Sasson. 1992. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119:493.
35. Griffith, T. S., T. Brunner, S. M. Fletcher, D. R. Green, and T. A. Ferguson. 1995. Fas ligand induced apoptosis as a mechanism of immune privilege. Science 270:1189.
36. + T cells. J. Immunol. 154:5071.
37. Vremec, D., M. Zorbas, R. Scollay, D. J. Saunders, C. F. Ardavin, L. Wu, and K. Shortman. 1992. The surface phenotype of dendritic cells purified from mouse thymus and spleen: investigation of the CD8 expression by a subpopulation of dendritic cells. J. Exp. Med. 176:47.
38. Fehsel, K., K.-D. Kröncke, K. L. Meyer, H. Huber, V. Wahn, and V. Kolb-Bachofen. 1995. Nitric oxide induces apoptosis in mouse thymocytes. J. Immunol. 155:2858.
39. + T cells during an immune response to HIV-I-pulsed dendritic cells. AIDS Res. Human Retroviruses 10:61.
40. Rastellini, C., L. Lu, C. Ricordi, T. E. Starzl, A. S. Rao, and A. W. Thomson. 1995. GM-CSF stimulated hepatic dendritic cell progenitors prolong pancreatic islet allograft survival. Transplantation 60:1366.
41. Reid, C. D. L., P. R. Fryer, C. Clifford, A. Kirk, J. Tikerpae, and S. C. Knight. 1990. Identification of hematopoietic progenitors of macrophages and dendritic Langerhans cells (DL-CFU) in human bone marrow and peripheral blood. Blood 76:1139.
42. Wu, M. X., Z. Ao, M. Hegen, C. Morimoto, and S. F. Schlossman. 1996. Requirement of Fas (CD95), CD45, and CD11a/CD18 in monocyte-dependent apoptosis of human T cells. J. Immunol. 157:707.
43. Munn, D. H., J. Pressey, A. C. Beall, R. Hudes, and M. R. Alderson. 1996. Selective activation induced apoptosis of peripheral T cells imposed by macrophages. J. Immunol. 156:523.
44. Hauschildt, S., W. G. Bessler, and P. Scheipers. 1993. Engagement of major histocompatibility complex class II molecules leads to nitrite production in bone marrow-derived macrophages. Eur. J. Immunol. 23:2988.
45. Tian, L., R. J. Noelle, and D. A. Lawrence, 1995. Activated T cells enhance nitric oxide production by murine splenic macrophages through gp39 and LFA-1. Eur. J. Immunol. 25:306.
46. Nagata, S. 1994. Fas and Fas ligand: a death factor and its receptor. Adv. Immunol. 57:129.
47. Brunner, T., R. J. Mogil, D. LaFace, N. J. Yoo, A. Mahboubi, F. Echeverri, S. J. Martin, W. R. Force, D. H. Lynch, C. F. Ware, and D. R. Green. 1995. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373:441.
48. Alderson, M. R., T. W. Tough, T. Davis-Smith, S. Braddy, B. Falk, K. A. Schooley, R. G. Goodwin, C. A. Smith, F. Ramsdell, and D. H. Lynch. 1995. Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med. 181:71.
49. Hahne, M., T. Renno, M. Schroeter, M. Irmler, L. French, T. Bornand, H. Robson MacDonald, and J. Tschopp. 1996. Activated B cells express functional Fas ligand. Eur. J. Immunol. 26:721.
50. Lee, R. K., J. Spielman, D. Y. Zhao, K. J. Olsen, and E. R. Podack. 1996. Perforin, Fas ligand, and tumor necrosis factor are the major cytotoxic molecules used by lymphokine-activated killer cells. J. Immunol. 157:1919.
51. Liles, W. C., P. A. Kiener, J. A. Ledbetter, A. Aruffo, and S. J. Klebanoff. 1996. Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils. J. Exp. Med. 184:429.
52. Noel, P. J., L. H. Boise, J. M. Green, and C. B. Thompson. 1996. CD28 co-stimulation prevents cell death during primary T cell activation. J. Immunol. 157:636.
53. L. Immunity 3:87.
54. Radvanyi, L. G., Y. Shi, H. Vaziri, A. Sharma, R. Dhala, G. B. Mills, and R. G. Miller. 1996. CD28 costimulation inhibits TCR-induced apoptosis during primary T ceil response. J. Immunol. 156:1788.
55. Sytwu, H.-K., R. S. Liblau, and H. O. McDevitt. 1996. The roles of Fas/APO-1 (CD95) and TNF in antigen-induced programmed cell death in T cell receptor transgenic mice. Immunity 5:17.
56. Zheng, L., G. Fisher, R. E. Miller, J. Peschon, D. H. Lynch, and M. J. Lenardo. 1995. Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 377:348.
57. Alderson, M. R., C. A. Smith, T. W. Tough, T. Davis-Smith, R. J. Armitage. B. Falk, E. Roux, E. Baker, G. R. Sutherland, W. S. Din, and R. G. Goodwin. 1994. Molecular and biological characterization of human 4-1BB and its ligand. Eur. J. Immunol. 24:2219.
58. Wiley, S. R., K. Schooley, P. J. Smolak, W. S. Din, C.-P. Huang, J. K. Nicholl, G. R. Sutherland, T. D. Smith, C. Rauch, C. A. Smith, and R. G. Goodwill. 1995. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3:673.
59. Kronin, V., K. Winkel, G. Suss, A. Kelso, W. Heath, J. Kirberg, H. von Boehmer, and K. Shortman. 1996. A subclass of dendritic cells regulates the response of naive CD8 T cells by limiting their IL-2 production. J. Immunol. 157:3819.
60. Lau, H. T., M. Yu, A. Fontana, and C. J. Stoeckert, Jr. 1996. Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice. Science 273:109.